Lanthanum carbonated-associated injury to the small intestine

Diagnostic Histopathology

Volumn 21, Issue 11, 2015, Pages 452-454

  Khurram, Muhammad ^a   Montgomery, Elizabeth ^b  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Kayexalate (sodium polystyrene sulfonate); Lanthanum carbonate; Patiromer; Renvela (sevelamer); Sodium zirconium cyclosilicate

Indexed keywords

AMLODIPINE; CLOTRIMAZOLE; COTRIMOXAZOLE; DOXAZOSIN MESYLATE; FINASTERIDE; IRON POLYSACCHARIDE; LANTHANUM CARBONATE; OXYCODONE; POLYSTYRENESULFONATE SODIUM; PREDNISONE; TAMSULOSIN;

ACUTE DISEASE; ACUTE ESOPHAGITIS; AGED; ANTIHYPERTENSIVE THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; CALCINOSIS; CASE REPORT; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; DUODENUM BIOPSY; END STAGE RENAL DISEASE; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS ULCER; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HISTIOCYTOSIS; HISTIOCYTE; HISTIOCYTOSIS; HUMAN; HYPERTENSION; INTESTINE INJURY; KIDNEY TRANSPLANTATION; LAMINA PROPRIA; MALE; MUCOSAL CALCINOSIS; PERITONEAL DIALYSIS; POSTOPERATIVE CARE; STOMACH BIOPSY; STOMACH ULCER; VOMITING;

EID: 84947434404     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2015.10.002     Document Type: Review

References (16)

1. Davis R.L., Abraham J.L. Lanthanum deposition in a dialysis patient. Nephrol Dial Transplant 2009, 24:3247-3250.
2. Damment S.J., Pennick M. Clinical pharmacokinetics of the phosphate binder lanthanum carbonate. Clin Pharmacokinet 2008, 47:553-563.
3. Bervoets A.R., Behets G.J., Schryvers D., et al. Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure. Kidney Int 2009, 75:389-398.
4. Makino M., Kawaguchi K., Shimojo H., Nakamura H., Nagasawa M., Kodama R. Extensive lanthanum deposition in the gastric mucosa: the first histopathological report. Pathol Int 2015, 65:33-37.
5. Haratake J., Yasunaga C., Ootani A., Shimajiri S., Matsuyama A., Hisaoka M. Peculiar histiocytic lesions with massive lanthanum deposition in dialysis patients treated with lanthanum carbonate. Am J Surg Pathol 2015, 39:767-771.
6. Zhang C., Wen J., Li Z., Fan J. Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review. BMC Nephrol 2013, 14:226.
7. Jamal S.A., Vandermeer B., Raggi P., et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 2013, 382:1268-1277.
8. Rothenberg M.E., Araya H., Longacre T.A., Pasricha P.J. Lanthanum-induced gastrointestinal histiocytosis. ACG Case Rep J 2015, 2:187-189.
9. Spasovski G.B., Sikole A., Gelev S., et al. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant 2006, 21:2217-2224.
10. Abraham S.C., Bhagavan B.S., Lee L.A., Rashid A., Wu T.T. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol 2001, 25:637-644.
11. Lillemoe K.D., Romolo J.L., Hamilton S.R., Pennington L.R., Burdick J.F., Williams G.M. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 1987, 101:267-272.
12. Rashid A., Hamilton S.R. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol 1997, 21:60-69.
13. Swanson B.J., Limketkai B.N., Liu T.C., et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol 2013, 37:1686-1693.
14. Kosiborod M., Peacock W.F., Packham D.K. Sodium zirconium cyclosilicate for urgent therapy of severe hyperkalemia. N Engl J Med 2015, 372:1577-1578.
15. Packham D.K., Rasmussen H.S., Lavin P.T., et al. Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med 2015, 372:222-231.
16. Weir M.R., Bakris G.L., Bushinsky D.A., et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 2015, 372:211-221.